-
公开(公告)号:US20170049882A1
公开(公告)日:2017-02-23
申请号:US15230736
申请日:2016-08-08
发明人: Darrell J. Irvine , Jaehyun Moon
IPC分类号: A61K39/385 , A61K39/39 , A61K47/48 , A61K39/21 , A61K9/127 , A61K39/015
CPC分类号: A61K39/385 , A61K9/127 , A61K9/1271 , A61K9/1273 , A61K38/193 , A61K38/20 , A61K38/2013 , A61K38/2046 , A61K38/208 , A61K38/2086 , A61K38/212 , A61K38/217 , A61K38/45 , A61K39/00 , A61K39/015 , A61K39/12 , A61K39/21 , A61K39/39 , A61K39/39533 , A61K47/6811 , A61K47/6911 , A61K2039/55511 , A61K2039/55555 , A61K2039/55572 , A61K2039/57 , A61K2039/572 , A61K2039/575 , A61K2039/6018 , C07K14/005 , C12N15/88 , C12N2740/15034 , C12N2740/16234 , C12Y207/10001 , Y02A50/412
摘要: The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles comprise terminal-cysteine-bearing antigens or cysteine-modified antigens, at their surface and/or internally.
摘要翻译: 本发明提供由稳定的多层泡囊组成的递送系统,以及组合物,合成方法及其使用方法。 稳定的多层囊泡在其表面和/或内部包含带有末端半胱氨酸的抗原或半胱氨酸修饰的抗原。
-
公开(公告)号:US09445994B2
公开(公告)日:2016-09-20
申请号:US14741694
申请日:2015-06-17
发明人: Darrell J. Irvine , Jaehyun Moon
IPC分类号: A61K9/127 , A61K39/395 , A61K38/21 , A61K38/45 , A61K38/19 , A61K38/20 , A61K39/015 , A61K39/21 , A61K39/39 , A61K47/48 , C07K14/005 , C12N15/88 , A61K39/12 , A61K39/00
CPC分类号: A61K39/385 , A61K9/127 , A61K9/1271 , A61K9/1273 , A61K38/193 , A61K38/20 , A61K38/2013 , A61K38/2046 , A61K38/208 , A61K38/2086 , A61K38/212 , A61K38/217 , A61K38/45 , A61K39/00 , A61K39/015 , A61K39/12 , A61K39/21 , A61K39/39 , A61K39/39533 , A61K47/6811 , A61K47/6911 , A61K2039/55511 , A61K2039/55555 , A61K2039/55572 , A61K2039/57 , A61K2039/572 , A61K2039/575 , A61K2039/6018 , C07K14/005 , C12N15/88 , C12N2740/15034 , C12N2740/16234 , C12Y207/10001 , Y02A50/412
摘要: The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles comprise terminal-cysteine-bearing antigens or cysteine-modified antigens, at their surface and/or internally.
-
公开(公告)号:US09907753B2
公开(公告)日:2018-03-06
申请号:US15452992
申请日:2017-03-08
发明人: Darrell J. Irvine , Jaehyun Moon
IPC分类号: A61K9/127 , C12N7/00 , C07K16/28 , C07K14/005 , A61K47/48 , A61K45/06 , A61K39/395 , A61K39/39 , A61K39/35 , A61K39/21 , A61K39/12 , A61K39/00 , A61K38/20 , A61K38/19 , A61K31/713 , A61K31/437
CPC分类号: A61K9/1271 , A61K9/127 , A61K9/1273 , A61K31/437 , A61K31/713 , A61K38/19 , A61K38/20 , A61K39/00 , A61K39/0005 , A61K39/0011 , A61K39/12 , A61K39/21 , A61K39/35 , A61K39/39 , A61K39/39558 , A61K45/06 , A61K47/48815 , A61K47/6911 , A61K2039/505 , A61K2039/55511 , A61K2039/55516 , A61K2039/55522 , A61K2039/55555 , A61K2039/55561 , A61K2039/55572 , A61K2039/572 , A61K2039/575 , C07K14/005 , C07K16/28 , C12N7/00 , C12N2740/16222 , C12N2740/16234 , Y10T428/2984
摘要: The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.
-
公开(公告)号:US20160303046A1
公开(公告)日:2016-10-20
申请号:US15097607
申请日:2016-04-13
发明人: Darrell J. Irvine , Jaehyun Moon
IPC分类号: A61K9/127 , A61K39/00 , A61K31/437 , C12N7/00 , A61K39/39 , A61K47/48 , A61K38/19 , A61K31/713 , A61K39/21
CPC分类号: A61K9/1271 , A61K9/127 , A61K9/1273 , A61K31/437 , A61K31/713 , A61K38/19 , A61K38/20 , A61K39/00 , A61K39/0005 , A61K39/0011 , A61K39/12 , A61K39/21 , A61K39/35 , A61K39/39 , A61K39/39558 , A61K45/06 , A61K47/48815 , A61K47/6911 , A61K2039/505 , A61K2039/55511 , A61K2039/55516 , A61K2039/55522 , A61K2039/55555 , A61K2039/55561 , A61K2039/55572 , A61K2039/572 , A61K2039/575 , C07K14/005 , C07K16/28 , C12N7/00 , C12N2740/16222 , C12N2740/16234 , Y10T428/2984
摘要: The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.
-
公开(公告)号:US09393199B2
公开(公告)日:2016-07-19
申请号:US13910937
申请日:2013-06-05
IPC分类号: A61K9/127 , A61K35/17 , A61K38/19 , A61K9/51 , A61K31/7105 , A61K31/711 , A61K38/20 , A61K45/06 , A61K47/48 , B82Y5/00 , C12N5/00 , C12N5/0783 , C12N5/0789 , C12N15/87 , A61K39/00 , A61K39/395 , A61K47/46 , A61K35/12
CPC分类号: A61K9/127 , A61K9/146 , A61K9/19 , A61K9/5146 , A61K9/5153 , A61K31/7105 , A61K31/711 , A61K35/28 , A61K38/19 , A61K38/20 , A61K38/2086 , A61K39/00 , A61K39/39 , A61K39/395 , A61K45/06 , A61K47/46 , A61K47/6901 , A61K47/6911 , A61K47/6937 , A61K2035/124 , B82Y5/00 , C07K16/00 , C12N5/0006 , C12N5/0636 , C12N5/0647 , C12N15/113 , C12N15/87 , C12N2310/14 , A61K2300/00
摘要: The invention provides compositions and methods for delivering agents to localized regions, tissues, or organs in vivo by conjugating agent-loaded nanoparticles to cells having homing capability. The agents may be therapeutic or diagnostic agents such as cancer chemotherapeutic agents and imaging agents respectively.
-
公开(公告)号:US08951542B2
公开(公告)日:2015-02-10
申请号:US14265924
申请日:2014-04-30
发明人: Darrell J. Irvine , Jaehyun Moon
IPC分类号: A61K9/00 , C12N5/071 , C07C51/347 , A61K47/00 , A61K9/127 , C07K16/28 , A61K39/12 , A61K39/35
CPC分类号: A61K9/1271 , A61K9/127 , A61K9/1273 , A61K31/437 , A61K31/713 , A61K38/19 , A61K38/20 , A61K39/00 , A61K39/0005 , A61K39/0011 , A61K39/12 , A61K39/21 , A61K39/35 , A61K39/39 , A61K39/39558 , A61K45/06 , A61K47/48815 , A61K47/6911 , A61K2039/505 , A61K2039/55511 , A61K2039/55516 , A61K2039/55522 , A61K2039/55555 , A61K2039/55561 , A61K2039/55572 , A61K2039/572 , A61K2039/575 , C07K14/005 , C07K16/28 , C12N7/00 , C12N2740/16222 , C12N2740/16234 , Y10T428/2984
摘要: The invention provides delivery systems comprised of stabilized multilamellar vesicles, as well as compositions, methods of synthesis, and methods of use thereof. The stabilized multilamellar vesicles may comprise prophylactic, therapeutic and/or diagnostic agents.
摘要翻译: 本发明提供由稳定的多层泡囊组成的递送系统,以及组合物,合成方法及其使用方法。 稳定的多层囊泡可以包含预防性,治疗和/或诊断剂。
-
-
-
-
-